<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="antiviral1\PMC7022795\results\search\drugs\results.xml">
  <result pre="for ages in traditional Chinese medicine [8]. The sesquiterpene lactone" exact="artemisinin" post="(ART), the active principle, was discovered in the 1970s."/>
  <result pre="use of ART as an antiviral. ART, dihydroartemisinin (DHA) and" exact="artesunate" post="(AS) were compared for their anti-HCMV effect in a"/>
  <result pre="release in a culture medium. Moreover, synergism with the antiviral" exact="lamivudine" post="was demonstrated [17]. ART downregulated the oncogenic human papillomavirus"/>
  <result pre="even higher than that of classical antiviral drugs, such as" exact="ganciclovir" post="[16,25,28]. The antiviral effect was confirmed against different, multidrug-resistant"/>
  <result pre="AS was synergistic with antiviral drugs such as maribavir [27,32,33]," exact="lamivudine" post="[17], ganciclovir [34], foscarnet, cidofovir, letermovir [33]. However, in"/>
  <result pre="synergistic with antiviral drugs such as maribavir [27,32,33], lamivudine [17]," exact="ganciclovir" post="[34], foscarnet, cidofovir, letermovir [33]. However, in vitro data"/>
  <result pre="the other hand, a renal transplant recipient patient with documented" exact="valganciclovir" post="resistance mutations in HCMV was treated with AS, with"/>
  <result pre="and to prevent recrudescence. One of these combinations, AS plus" exact="amodiaquine" post="(AQ), was tested against HCMV in a clinical study"/>
  <result pre="based on transgenic viral strain. Compared to AS and/or ART," exact="artemether" post="was the most active. However, the activity was only"/>
  <result pre="effect of the aryl-aminoalcohol compounds quinine sulfate, mefloquine, halofantrine, and" exact="lumefantrine" post="on both classical and emerging viruses has been studied."/>
  <result pre="still playing a pivotal role, especially in the treatment of" exact="chloroquine" post="(CQ)-resistant Plasmodium falciparum [65,66]. Due to the benefit derived"/>
  <result pre="of the infection, with a claimed effect of MQ and" exact="mirtazapine" post="treatment [86,87,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105], and to the resolution of the infection"/>
  <result pre="difficult to determine [118,119]. MQ has also been combined with" exact="risperidone" post="[75] or risperidone and cytarabine [120], and the final"/>
  <result pre="[118,119]. MQ has also been combined with risperidone [75] or" exact="risperidone" post="and cytarabine [120], and the final outcomes were opposing,"/>
  <result pre="has also been combined with risperidone [75] or risperidone and" exact="cytarabine" post="[120], and the final outcomes were opposing, either death"/>
  <result pre="death of the patient [126]. The combined treatment MQ and" exact="mirtazapine" post="was administered to HIV-positive patients, leading to a failure"/>
  <result pre="of the three best combinations was composed of MQ with" exact="toremifene" post="(an antagonist of estrogen receptors) and the antifungal posaconazole,"/>
  <result pre="and MQ as antivirals, the same cannot be stated for" exact="halofantrine" post="and lumefantrine, which failed in the inhibition of viral"/>
  <result pre="of ~2500 compounds, were able to describe inhibition activity of" exact="halofantrine" post="on Semliki Forest virus (SFV) and DENV-2, but, due"/>
  <result pre="the treatment of different diseases. Currently, CQ and its hydroxy-analog" exact="hydroxychloroquine" post="(hydroxyCQ) cannot be used as antimalarial drugs in wide"/>
  <result pre="plasma level, although at a lower level than the antiviral" exact="zidovudine" post="[40]. In contrast, the results published in 2012 by"/>
  <result pre="infected by Newcastle disease virus [164]. It was demonstrated that" exact="primaquine" post="had an effect on the accumulation of viral hemagglutinin"/>
  <result pre="accumulation of viral hemagglutinin on the cell surface. In addition," exact="primaquine" post="inhibited protein synthesis in virus-infected cells [164]. 5. Other"/>
  <result pre="one published work reported the in vitro antiviral action of" exact="atovaquone" post="against CHIKV. Low micromolar doses inhibited the number of"/>
  <result pre="the same paper, Kottkamp and colleagues evaluated the ability of" exact="atovaquone" post="to reduce the infectivity of both a Brazilian and"/>
  <result pre="Ugandan strain [166]. 5.2. Antimicrobial Drugs Antibiotic drugs, such as" exact="doxycycline" post="and sulfonamides, are widely used in the chemoprophylaxis of"/>
  <result pre="been completely investigated. 5.2.1. Doxycycline Doxycycline (DOX) is a semisynthetic" exact="tetracycline" post="antibiotic that prevents bacterial protein synthesis by acting on"/>
  <result pre="agents with broad-spectrum bacteriostatic activity. Sulfonamides interrupt the synthesis of" exact="folic acid," post="interfering with the dihydropteroate synthase and dihydrofolate reductase enzymes"/>
  <result pre="Human cytomegalovirus HCV Hepatitis C virus HPV Human papillomavirus hydroxyCQ" exact="hydroxychloroquine" post="IL Interleukin INF Interferon KSHV Kaposi sarcoma herpesvirus MQ"/>
  <result pre="activity of artemisinin—From bench to bedsidePlanta Med.20077329930910.1055/s-2007-96713817354163 10.EfferthT.MarschallM.WangX.HuongS.M.HauberI.OlbrichA.KronschnablM.StammingerT.HuangE.S.Antiviral activity of" exact="artesunate" post="towards wild-type, recombinant, and ganciclovir-resistant human cytomegalovirusesJ. Mol. Med.20028023324210.1007/s00109-001-0300-811976732"/>
  <result pre="recombinant, and ganciclovir-resistant human cytomegalovirusesJ. Mol. Med.20028023324210.1007/s00109-001-0300-811976732 11.KapteinS.J.EfferthT.LeisM.RechterS.AuerochsS.KalmerM.BruggemanC.A.VinkC.StammingerT.MarschallM.The anti-malaria drug" exact="artesunate" post="inhibits replication of cytomegalovirus in vitro and in vivoAntivir."/>
  <result pre="transplantationClin. Infect. Dis.2008461455145710.1086/58710618419454 13.WolfD.G.ShimoniA.ResnickI.B.StammingerT.NeumannA.U.ChouS.EfferthT.CaplanO.RoseJ.NaglerA.et al.Human cytomegalovirus kinetics following institution of" exact="artesunate" post="after hematopoietic stem cell transplantationAntivir. Res.20119018318610.1016/j.antiviral.2011.03.18421443904 14.EfferthT.RomeroM.R.WolfD.G.StammingerT.MarinJ.J.MarschallM.The antiviral activities"/>
  <result pre="after hematopoietic stem cell transplantationAntivir. Res.20119018318610.1016/j.antiviral.2011.03.18421443904 14.EfferthT.RomeroM.R.WolfD.G.StammingerT.MarinJ.J.MarschallM.The antiviral activities of" exact="artemisinin" post="and artesunateClin. Infect. Dis.20084780481110.1086/59119518699744 15.EfferthT.Beyond malaria: The inhibition of"/>
  <result pre="compoundsBiotechnol. Adv.2018361730173710.1016/j.biotechadv.2018.01.00129305894 16.FlobinusA.TaudonN.DesbordesM.LabrosseB.SimonF.MazeronM.C.SchnepfN.Stability and antiviral activity against human cytomegalovirus of" exact="artemisinin" post="derivativesJ. Antimicrob. Chemother.201469344010.1093/jac/dkt34624003183 17.RomeroM.R.EfferthT.SerranoM.A.CastañoB.MaciasR.I.BrizO.MarinJ.J.Effect of artemisinin/artesunate as inhibitors of"/>
  <result pre="on HIV-1 replicationVirus Res.201015326927610.1016/j.virusres.2010.08.01820800626 24.ZengA.H.OuY.Y.GuoM.M.DaiX.ZhouD.Z.ChenR.Human embryonic lung fibroblasts treated with" exact="artesunate" post="exhibit reduced rates of proliferation and human cytomegalovirus infection"/>
  <result pre="human cytomegalovirus infection in vitroJ. Thorac. Dis.201571151115710.3978/j.issn.2072-1439.2015.07.0526380730 25.SchnepfN.CorvoJ.PorsM.J.MazeronM.C.Antiviral activity of" exact="ganciclovir" post="and artesunate towards human cytomegalovirus in astrocytoma cellsAntivir. Res.20118918618810.1016/j.antiviral.2010.12.00221167209"/>
  <result pre="infection in vitroJ. Thorac. Dis.201571151115710.3978/j.issn.2072-1439.2015.07.0526380730 25.SchnepfN.CorvoJ.PorsM.J.MazeronM.C.Antiviral activity of ganciclovir and" exact="artesunate" post="towards human cytomegalovirus in astrocytoma cellsAntivir. Res.20118918618810.1016/j.antiviral.2010.12.00221167209 26.HeR.FormanM.MottB.T.VenkatadriR.PosnerG.H.Arav-BogerR.Unique and"/>
  <result pre="diphenyl phosphate moietyAntimicrob. Agents Chemother.2013574208421410.1128/AAC.00893-1323774439 27.ChouS.MarousekG.AuerochsS.StammingerT.MilbradtJ.MarschallM.The unique antiviral activity of" exact="artesunate" post="is broadly effective against human cytomegaloviruses including therapy-resistant mutantsAntivir."/>
  <result pre="against human cytomegaloviruses including therapy-resistant mutantsAntivir. Res.20119236436810.1016/j.antiviral.2011.07.01821843554 28.ReiterC.FröhlichT.ZeinoM.MarschallM.BahsiH.LeidenbergerM.FriedrichO.KappesB.HampelF.EfferthT.et al.New efficient" exact="artemisinin" post="derived agents against human leukemia cells, human cytomegalovirus and"/>
  <result pre="1,2,4-trioxane-ferrocene hybridsEur. J. Med. Chem.20159716417210.1016/j.ejmech.2015.04.05325965779 29.HuttererC.NiemannI.MilbradtJ.FröhlichT.ReiterC.KadiogluO.BahsiH.ZeitträgerI.WagnerS.EinsiedelJ.et al.The broad-spectrum antiinfective drug" exact="artesunate" post="interferes with the canonical nuclear factor kappa B (NF-κB)"/>
  <result pre="insights into mechanisms of ActionAntimicrob. Agents Chemother.20145898699410.1128/AAC.01972-1324277030 35.CanivetC.MenasriaR.RhéaumeC.PiretJ.BoivinG.Valacyclovir combined with" exact="artesunate" post="or rapamycin improves the outcome of herpes simplex virus"/>
  <result pre="Inst. Oswaldo. Cruz.201310859659910.1590/S0074-0276201300050001023903975 37.De LamballerieX.BoissonV.ReynierJ.C.EnaultS.CharrelR.N.FlahaultA.RoquesP.Le GrandR.On chikungunya acute infection and" exact="chloroquine" post="treatmentVector Borne Zoonotic Dis.2008883783910.1089/vbz.2008.004918620511 38.PatonN.I.LeeL.XuY.OoiE.E.CheungY.B.ArchuletaS.WongG.Wilder-SmithA.SmithA.W.Chloroquine for influenza prevention: A"/>
  <result pre="patients with human immunodeficiency virus type 1Clin. Ther.19951762263610.1016/0149-2918(95)80039-58565026 40.SperberK.ChiangG.ChenH.RossW.ChusidE.GoncharM.ChowR.LirianoO.Comparison of" exact="hydroxychloroquine" post="with zidovudine in asymptomatic patients infected with human immunodeficiency"/>
  <result pre="human immunodeficiency virus type 1Clin. Ther.19951762263610.1016/0149-2918(95)80039-58565026 40.SperberK.ChiangG.ChenH.RossW.ChusidE.GoncharM.ChowR.LirianoO.Comparison of hydroxychloroquine with" exact="zidovudine" post="in asymptomatic patients infected with human immunodeficiency virus type"/>
  <result pre="with human immunodeficiency virus type 1Clin. Ther.19971991392310.1016/S0149-2918(97)80045-89385480 41.PatonN.I.GoodallR.L.DunnD.T.FranzenS.Collaco-MoraesY.GazzardB.G.WilliamsI.G.FisherM.J.WinstonA.FoxJ.et al.Effects of" exact="hydroxychloroquine" post="on immune activation and disease progression among HIV-infected patients"/>
  <result pre="with HIV-1AIDS Res. Hum. Retrovir.20163263664710.1089/aid.2015.033626935044 43.MurrayS.M.DownC.M.BoulwareD.R.StaufferW.M.CavertW.P.SchackerT.W.BrenchleyJ.M.DouekD.C.Reduction of immune activation with" exact="chloroquine" post="therapy during chronic HIV infectionJ. Virol.201084120821208610.1128/JVI.01466-1020844049 44.RoutyJ.P.AngelJ.B.PatelM.KanagarathamC.RadziochD.KemaI.GilmoreN.AncutaP.SingerJ.JenabianM.A.Assessment of chloroquine"/>
  <result pre="with chloroquine therapy during chronic HIV infectionJ. Virol.201084120821208610.1128/JVI.01466-1020844049 44.RoutyJ.P.AngelJ.B.PatelM.KanagarathamC.RadziochD.KemaI.GilmoreN.AncutaP.SingerJ.JenabianM.A.Assessment of" exact="chloroquine" post="as a modulator of immune activation to improve CD4"/>
  <result pre="A randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly" exact="chloroquine" post="among adults on antiretroviral therapy in Malawi: Study protocol"/>
  <result pre="multidrug-resistant cytomegalovirus diseaseTranspl. Infect. Dis.20151775175510.1111/tid.1243526432076 48.GermiR.MarietteC.AlainS.LupoJ.ThiebautA.BrionJ.P.EpaulardO.Saint RaymondC.MalvezziP.MorandP.Success and failure of" exact="artesunate" post="treatment in five transplant recipients with disease caused by"/>
  <result pre="compounds in HHV-6-infected lymphoblastsJ. Clin. Virol.200637Suppl. S1S69S7510.1016/S1386-6532(06)70015-417276373 54.SharmaB.N.MarschallM.RinaldoC.H.Antiviral effects of" exact="artesunate" post="on JC polyomavirus replication in COS-7 cellsAntimicrob. Agents Chemother.2014586724673410.1128/AAC.03714-1425155602"/>
  <result pre="polyomavirus replication in COS-7 cellsAntimicrob. Agents Chemother.2014586724673410.1128/AAC.03714-1425155602 55.SharmaB.N.MarschallM.HenriksenS.RinaldoC.H.Antiviral effects of" exact="artesunate" post="on polyomavirus BK replication in primary human kidney cellsAntimicrob."/>
  <result pre="Dis.20196ofz25010.1093/ofid/ofz25031281856 61.Arav-BogerR.HeR.ChiouC.J.LiuJ.WoodardL.RosenthalA.Jones-BrandoL.FormanM.PosnerG.Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to" exact="artemisinin" post="monomersPLoS ONE20105e1037010.1371/journal.pone.001037020442781 62.MottB.T.HeR.ChenX.FoxJ.M.CivinC.I.Arav-BogerR.PosnerG.H.Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus"/>
  <result pre="anti-cancer agents: A structure-activity studyBioorg. Med. Chem.2013213702370710.1016/j.bmc.2013.04.02723673218 63.BlazquezA.G.Fernandez-DolonM.Sanchez-VicenteL.MaestreA.D.Gomez-San MiguelA.B.AlvarezM.SerranoM.A.JansenH.EfferthT.MarinJ.J.et al.Novel" exact="artemisinin" post="derivatives with potential usefulness against liver/colon cancer and viral"/>
  <result pre="targeting broad host cell pathwaysPLoS ONE20149e11063110.1371/journal.pone.011063125333287 71.BrickelmaierM.LugovskoyA.KartikeyanR.Reviriego-MendozaM.M.AllaireN.SimonK.FrisqueR.J.GorelikL.Identification and characterization of" exact="mefloquine" post="efficacy against JC virus in vitroAntimicrob. Agents Chemother.2009531840184910.1128/AAC.01614-0819258267 72.KishidaS.TanakaK.Mefloquine"/>
  <result pre="a patient with systemic lupus erythematosusIntern. Med.2012511245124710.2169/internalmedicine.51.681022687798 75.KobayashiZ.AkazaM.NumasawaY.IshiharaS.TomimitsuH.NakamichiK.SaijoM.MorioT.ShimizuN.SanjoN.et al.Failure of" exact="mefloquine" post="therapy in progressive multifocal leukoencephalopathy: Report of two Japanese"/>
  <result pre="leukoencephalopathy derived from non-Hodgkin lymphoma: Neuropathological findings and results of" exact="mefloquine" post="treatmentIntern. Med.20155496597010.2169/internalmedicine.54.230825876582 81.GarroteH.de la FuenteA.OñaR.RodríguezI.EchevarríaJ.E.SepúlvedaJ.M.GarcíaJ.F.Long-term survival in a patient"/>
  <result pre="a patient with progressive multifocal leukoencephalopathy after therapy with rituximab," exact="fludarabine" post="and cyclophosphamide for chronic lymphocytic leukemiaExp. Hematol. Oncol.20154810.1186/s40164-015-0003-425767742 82.YoshidaT.KawamotoM.TogoM.KoharaN.ItoT.NakamichiK.SaijoM.MizunoT.Progressive"/>
  <result pre="with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and" exact="cyclophosphamide" post="for chronic lymphocytic leukemiaExp. Hematol. Oncol.20154810.1186/s40164-015-0003-425767742 82.YoshidaT.KawamotoM.TogoM.KoharaN.ItoT.NakamichiK.SaijoM.MizunoT.Progressive multifocal leukoencephalopathy"/>
  <result pre="of imaging findings: A case reportJ. Neurol. Sci.20153591310.1016/j.jns.2015.10.02826671076 83.HirayamaM.NosakiY.MatsuiK.TeraoS.KuwayamaM.TateyamaH.YoshidaM.HashizumeY.Efficacy of" exact="mefloquine" post="to progressive multifocal leukoencephalopathy initially presented with parkinsonismClin. Neurol."/>
  <result pre="the outcome after natalizumab-associated progressive multifocal leukoencephalopathyFront. Neurol.201341110.3389/fneur.2013.0001123423248 94.EpperlaN.Medina-FloresR.MazzaJ.J.YaleS.H.Mirtazapine and" exact="mefloquine" post="therapy for non-AIDS-related progressive multifocal leukoencephalopathyWMJ201411324224525745699 95.KurmannR.WeisstannerC.KardasP.HirschH.H.WiestR.LämmleB.FurrerH.Du PasquierR.BassettiC.L.SturzeneggerM.et al.Progressive"/>
  <result pre="al.Progressive multifocal leukoencephalopathy in common variable immunodeficiency: Mitigated course under" exact="mirtazapine" post="and mefloquineJ. Neurovirol.20152169470110.1007/s13365-015-0340-425916731 96.BalakD.M.W.HajdarbegovicE.BramerW.M.NeumannH.A.M.ThioH.B.Progressive multifocal leukoencephalopathy associated with fumaric"/>
  <result pre="Eur. Acad. Dermatol. Venereol.2017311475148210.1111/jdv.1423628322482 97.YoshidaH.OhshimaK.TodaJ.KusakabeS.MasaieH.YagiT.IshikawaJ.Significant improvement following combination treatment with" exact="mefloquine" post="and mirtazapine in a patient with progressive multifocal leukoencephalopathy"/>
  <result pre="Dermatol. Venereol.2017311475148210.1111/jdv.1423628322482 97.YoshidaH.OhshimaK.TodaJ.KusakabeS.MasaieH.YagiT.IshikawaJ.Significant improvement following combination treatment with mefloquine and" exact="mirtazapine" post="in a patient with progressive multifocal leukoencephalopathy after allogeneic"/>
  <result pre="intravenous immunoglobulin in a patient with multiple sclerosis treated with" exact="fingolimod" post="after discontinuation of natalizumabJ. Clin. Neurosci.20152259860010.1016/j.jocn.2014.08.01625523125 99.SilverioK.A.PatelS.A.Progressive Multifocal Leukoencephalopathy"/>
  <result pre="Cancer TherapyCase Rep. Oncol. Med.2015201553452910.1155/2015/53452926788389 100.Fabis-PedriniM.J.XuW.BurtonJ.CarrollW.M.KermodeA.G.Asymptomatic progressive multifocal leukoencephalopathy during" exact="natalizumab" post="therapy with treatmentJ. Clin. Neurosci.20162514514710.1016/j.jocn.2015.08.02726541323 101.IkedaJ.MatsushimaA.IshiiW.GotoT.TakahashiK.NakamichiK.SaijoM.SekijimaY.IkedaS.I.Brain Biopsy Is More"/>
  <result pre="a 44-year old male with idiopathic CD4+ T-lymphocytopenia treated with" exact="mirtazapine" post="and mefloquineNeurol. India2017651061106410.4103/neuroindia.NI_535_1628879898 103.IshikawaY.KasuyaT.IshikawaJ.FujiwaraM.KitaY.A case of developing progressive multifocal"/>
  <result pre="India2017651061106410.4103/neuroindia.NI_535_1628879898 103.IshikawaY.KasuyaT.IshikawaJ.FujiwaraM.KitaY.A case of developing progressive multifocal leukoencephalopathy while using" exact="rituximab" post="and mycophenolate mofetil in refractory systemic lupus erythematosusTher. Clin."/>
  <result pre="107.HarelA.HorngS.GustafsonT.RamineniA.FarberR.S.FabianM.Successful treatment of progressive multifocal leukoencephalopathy with recombinant interleukin-7 and" exact="maraviroc" post="in a patient with idiopathic CD4 lymphocytopeniaJ. Neurovirol.20182465265510.1007/s13365-018-0657-x29987583 108.ZhangY.WrightC.FloresA.Asymptomatic"/>
  <result pre="al.Progressive multifocal leukoencephalopathy after T-cell replete HLA-haploidentical transplantation with post-transplantation" exact="cyclophosphamide" post="graft-versus-host disease prophylaxisTranspl. Infect. Dis.201820e1285010.1111/tid.1285029359846 114.LutzM.SchulzeA.B.RebberE.WiebeS.ZoubiT.GrauerO.M.KeßlerT.KerkhoffA.LenzG.BerdelW.E.Progressive Multifocal Leukoencephalopathy after"/>
  <result pre="Response to Mefloquine TreatmentIntern. Med.2016551631163510.2169/internalmedicine.55.605127301518 121.HervásJ.V.Presas-RodríguezS.Crespo-CuevasA.M.CanentoT.Lozano-SánchezM.Massuet-VilamajóA.Ramo-TelloC.Progressive multifocal leukoencephalopathy associated to" exact="natalizumab" post="extended dosing regimenNeurodegener. Dis. Manag.2015539940210.2217/nmt.15.4226517599 122.MikitaK.MaedaT.FujikuraY.KozakiY.HaraY.KanohS.KishidaS.SaijoM.NakamichiK.KawanaA.Does anti-JCV therapy improve"/>
  <result pre="Inflammatory Syndrome (PML-IRIS): Two case reports of successful treatment with" exact="mefloquine" post="and a review of the literatureAnn. Acad. Med. Singap.20124162062423303123"/>
  <result pre="Acad. Med. Singap.20124162062423303123 124.AdachiE.KoibuchiT.ImaiK.KikuchiT.KogaM.NakamuraH.MiuraT.IwamotoA.FujiiT.Favourable outcome of progressive multifocal leukoencephalopathy with" exact="mefloquine" post="treatment in combination with antiretroviral therapy in an HIV-infected"/>
  <result pre="virus and JC virus infectionJ. Clin. Exp. Hematop.20145421121710.3960/jslrt.54.21125501112 127.MoensterR.P.JettR.A.Mirtazapine and" exact="mefloquine" post="therapy for progressive multifocal leukoencephalopathy in a patient infected"/>
  <result pre="control region rearrangements and host immunityJ. Neurovirol.20131927427910.1007/s13365-013-0167-923715894 129.CliffordD.B.NathA.CinqueP.BrewB.J.ZivadinovR.GorelikL.ZhaoZ.DudaP.A study of" exact="mefloquine" post="treatment for progressive multifocal leukoencephalopathy: Results and exploration of"/>
  <result pre="Res.201713716517210.1016/j.antiviral.2016.11.01727890675 133.NevinR.L.A serious nightmare: Psychiatric and neurologic adverse reactions to" exact="mefloquine" post="are serious adverse reactionsPharmacol. Res. Perspect.2017510.1002/prp2.32828805982 134.MazzonM.Ortega-PrietoA.M.ImrieD.LuftC.HessL.CziesoS.GroveJ.SkeltonJ.K.FarleighL.BugertJ.J.et al.Identification of"/>
  <result pre="manifestations from malaria to multifarious diseasesJ. Antimicrob. Chemother.2015701608162110.1093/jac/dkv01825693996 136.ShimizuY.YamamotoS.HommaM.IshidaN.Effect of" exact="chloroquine" post="on the growth of animal virusesArch. Gesamte Virusforsch.1972369310410.1007/BF012502994335025 137.InglotA.D.Comparison"/>
  <result pre="138.KhanM.SanthoshS.R.TiwariM.Lakshmana RaoP.V.ParidaM.Assessment of in vitro prophylactic and therapeutic efficacy of" exact="chloroquine" post="against Chikungunya virus in vero cellsJ. Med. Virol.20108281782410.1002/jmv.2166320336760 139.SourisseauM.SchilteC.CasartelliN.TrouilletC.Guivel-BenhassineF.RudnickaD.Sol-FoulonN.Le"/>
  <result pre="RouxK.PrevostM.C.FsihiH.et al.Characterization of reemerging chikungunya virusPLoS Pathog.20073e8910.1371/journal.ppat.003008917604450 140.HanY.MesplèdeT.XuH.QuanY.WainbergM.A.The antimalarial drug" exact="amodiaquine" post="possesses anti-ZIKA virus activitiesJ. Med. Virol.20189079680210.1002/jmv.2503129315671 141.DelvecchioR.HigaL.M.PezzutoP.ValadãoA.L.GarcezP.P.MonteiroF.L.LoiolaE.C.DiasA.A.SilvaF.J.AliotaM.T.et al.Chloroquine, an"/>
  <result pre="SARS coronavirus infection and spreadVirol. J.200526910.1186/1743-422X-2-6916115318 146.KeyaertsE.LiS.VijgenL.RysmanE.VerbeeckJ.Van RanstM.MaesP.Antiviral activity of" exact="chloroquine" post="against human coronavirus OC43 infection in newborn miceAntimicrob. Agents"/>
  <result pre="endocytosisJ. Virol.2006806964697210.1128/JVI.00024-0616809302 149.MizuiT.YamashinaS.TanidaI.TakeiY.UenoT.SakamotoN.IkejimaK.KitamuraT.EnomotoN.SakaiT.et al.Inhibition of hepatitis C virus replication by" exact="chloroquine" post="targeting virus-associated autophagyJ. Gastroenterol.20104519520310.1007/s00535-009-0132-919760134 150.Al-BariM.A.A.Targeting endosomal acidification by chloroquine"/>
  <result pre="by chloroquine targeting virus-associated autophagyJ. Gastroenterol.20104519520310.1007/s00535-009-0132-919760134 150.Al-BariM.A.A.Targeting endosomal acidification by" exact="chloroquine" post="analogs as a promising strategy for the treatment of"/>
  <result pre="Retrovir.1990648148910.1089/aid.1990.6.4811692728 152.SperberK.KalbT.H.StecherV.J.BanerjeeR.MayerL.Inhibition of human immunodeficiency virus type 1 replication by" exact="hydroxychloroquine" post="in T cells and monocytesAIDS Res. Hum. Retrovir.19939919810.1089/aid.1993.9.918427717 153.ChiangG.SassaroliM.LouieM.ChenH.StecherV.J.SperberK.Inhibition"/>
  <result pre="anti-HIV-1 activity of chloroquineJ. Clin. Virol.20012013113510.1016/S1386-6532(00)00139-611166661 155.BoelaertJ.R.PietteJ.SperberK.The potential place of" exact="chloroquine" post="in the treatment of HIV-1-infected patientsJ. Clin. Virol.20012013714010.1016/S1386-6532(00)00140-211166662 156.SavarinoA.LuciaM.B.RastrelliE.RutellaS.GolottaC.MorraE.TamburriniE.PernoC.F.BoelaertJ.R.SperberK.et"/>
  <result pre="synergism with protease inhibitorsJ. Acquir. Immune. Defic. Syndr.20043522323210.1097/00126334-200403010-0000215076236 157.NaardingM.A.BaanE.PollakisG.PaxtonW.A.Effect of" exact="chloroquine" post="on reducing HIV-1 replication in vitro and the DC-SIGN"/>
  <result pre="NucleotidesJ. Virol.20199310.1128/JVI.00389-1930894466 167.CastelliF.OdoliniS.AutinoB.FocaE.RussoR.Malaria Prophylaxis: A Comprehensive ReviewPharmaceuticals201033212323910.3390/ph3103212 168.RothanH.A.MohamedZ.PaydarM.RahmanN.A.YusofR.Inhibitory effect of" exact="doxycycline" post="against dengue virus replication in vitroArch. Virol.201415971171810.1007/s00705-013-1880-724142271 169.RothanH.A.BahraniH.MohamedZ.TeohT.C.ShankarE.M.RahmanN.A.YusofR.A combination"/>
  <result pre="against dengue virus replication in vitroArch. Virol.201415971171810.1007/s00705-013-1880-724142271 169.RothanH.A.BahraniH.MohamedZ.TeohT.C.ShankarE.M.RahmanN.A.YusofR.A combination of" exact="doxycycline" post="and ribavirin alleviated chikungunya infectionPLoS ONE201510e012636010.1371/journal.pone.012636025970853 170.WuZ.C.WangX.WeiJ.C.LiB.B.ShaoD.H.LiY.M.LiuK.ShiY.Y.ZhouB.QiuY.F.et al.Antiviral activity"/>
  <result pre="virus replication in vitroArch. Virol.201415971171810.1007/s00705-013-1880-724142271 169.RothanH.A.BahraniH.MohamedZ.TeohT.C.ShankarE.M.RahmanN.A.YusofR.A combination of doxycycline and" exact="ribavirin" post="alleviated chikungunya infectionPLoS ONE201510e012636010.1371/journal.pone.012636025970853 170.WuZ.C.WangX.WeiJ.C.LiB.B.ShaoD.H.LiY.M.LiuK.ShiY.Y.ZhouB.QiuY.F.et al.Antiviral activity of doxycycline"/>
  <result pre="and ribavirin alleviated chikungunya infectionPLoS ONE201510e012636010.1371/journal.pone.012636025970853 170.WuZ.C.WangX.WeiJ.C.LiB.B.ShaoD.H.LiY.M.LiuK.ShiY.Y.ZhouB.QiuY.F.et al.Antiviral activity of" exact="doxycycline" post="against vesicular stomatitis virus in vitroFEMS Microbiol. Lett.201536210.1093/femsle/fnv195 171.NgH.H.NarasarajuT.PhoonM.C.SimM.K.SeetJ.E.ChowV.T.Doxycycline"/>
  <result pre="metalloproteinasesExp. Mol. Pathol.20129228729510.1016/j.yexmp.2012.03.00322421441 172.ZhuJ.LiuS.LiuZ.LiY.TianJ.HuX.A highly sensitive and selective assay of" exact="doxycycline" post="by dualwavelength overlapping resonance Rayleigh scatteringSpectrochim. Acta A Mol."/>
  <result pre="liver transplantationTranspl. Infect. Dis.20121432632910.1111/j.1399-3062.2011.00709.x22260451 174.WalterM.S.FrankM.J.SatuéM.MonjoM.RønoldH.J.LyngstadaasS.P.HaugenH.J.Bioactive implant surface with electrochemically bound" exact="doxycycline" post="promotes bone formation markers in vitro and in vivoDent."/>
  <result pre="on 15 December 2019) 176.BriolantS.WurtzN.ZettorA.RogierC.PradinesB.Susceptibility of Plasmodium falciparum isolates to" exact="doxycycline" post="is associated with pftetQ sequence polymorphisms and pftetQ and"/>
  <result pre="cell linesCan. J. Physiol. Pharmacol.20169452653310.1139/cjpp-2015-048126913972 178.YangJ.M.ChenY.F.TuY.Y.YenK.R.YangY.L.Combinatorial computational approaches to identify" exact="tetracycline" post="derivatives as flavivirus inhibitorsPLoS ONE20072e42810.1371/journal.pone.000042817502914 179.BhattacharjeeM.K.Antimetabolites: Antibiotics That Inhibit"/>
  <result pre="for the evaluation of antiviral agentsAntivir. Res.20036011510.1016/S0166-3542(03)00174-814516916 188.RomeroM.R.SerranoM.A.VallejoM.EfferthT.AlvarezM.MarinJ.J.Antiviral effect of" exact="artemisinin" post="from Artemisia annua against a model member of the"/>
  <result pre="Mefloquine No PML progression [72,73,74,77,78,79,81,82,83,84,86,87] Fatal outcome [75,76,80,85,88] Mefloquine +" exact="mirtazapine" post="PML resolution with claimed effects [86,87,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105] PML resolution due"/>
  <result pre="[87,96,110,111,112,113,114,115,116] Therapy suspension due to side effects [117] Mefloquine +" exact="mirtazapine" post="+ third partner drug PML resolution [118] Fatal outcome"/>
  <result pre="partner drug PML resolution [118] Fatal outcome [119] Mefloquine +" exact="risperidone" post="Fatal outcome [75] Mefloquine + risperidone + cytarabine PML"/>
  <result pre="outcome [119] Mefloquine + risperidone Fatal outcome [75] Mefloquine +" exact="risperidone" post="+ cytarabine PML resolution [120] Mefloquine + cidofovir PML"/>
  <result pre="Mefloquine + risperidone Fatal outcome [75] Mefloquine + risperidone +" exact="cytarabine" post="PML resolution [120] Mefloquine + cidofovir PML resolution due"/>
  <result pre="Mefloquine + risperidone + cytarabine PML resolution [120] Mefloquine +" exact="cidofovir" post="PML resolution due to other factors [121] HIV positive"/>
  <result pre="Mefloquine No PML progression [122,123,124,125] Fatal outcome [126] Mefloquine +" exact="mirtazapine" post="Premature fatal outcome [127,128] Clinical Trial HIV negative versus"/>
  <result pre="HIV positive patients Standard of care (SOC) versus SOC +" exact="mefloquine" post="Lack of differences: study ended prematurely [129] microorganisms-08-00085-t003_Table 3Table"/>
  <result pre="in vitro [54] Mefloquine in vitro [71] Hepadnaviridae HBV Artemisinin," exact="artesunate" post="in vitro [17] Papillomaviridae HPV Artemisinin in vitro [18]"/>
  <result pre="Filoviridae EBOV Chloroquine in vitro [142,143] in vivo [142] Artesunate," exact="amodiaquine" post="in vivo [58] Mefloquine in vitro [132] Retroviridae HIV"/>
  <result pre="Artemisinin in vitro [23] Doxycycline in vitro [23] Mefloquine, toremifene," exact="posaconazole" post="in vitro [132] Chloroquine in vitro [151,157,158] in vivo"/>
  <result pre="vitro [132] Chloroquine in vitro [151,157,158] in vivo [155] Chloroquine," exact="hydroxychloroquine" post="in vitro [152,153,154,156] Phenuiviridae SFTSV Amodiaquine In vitro [163]"/>
  <result pre="Artesunate [52] Polyomaviridae JCPyV Artesunate [54,55] Mefloquine [72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,122,123,124,125,126] Mefloquine and" exact="mirtazapine" post="[86,87,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,127,128] Mefloquine, mirtazapine and a third drug [118,119] Mefloquine"/>
  <result pre="JCPyV Artesunate [54,55] Mefloquine [72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,122,123,124,125,126] Mefloquine and mirtazapine [86,87,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,127,128] Mefloquine," exact="mirtazapine" post="and a third drug [118,119] Mefloquine and risperidone [75]"/>
  <result pre="[86,87,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,127,128] Mefloquine, mirtazapine and a third drug [118,119] Mefloquine and" exact="risperidone" post="[75] Mefloquine, risperidone and cytarabine [120] Mefloquine and cidofovir"/>
  <result pre="and a third drug [118,119] Mefloquine and risperidone [75] Mefloquine," exact="risperidone" post="and cytarabine [120] Mefloquine and cidofovir [121] Mefloquine and"/>
  <result pre="third drug [118,119] Mefloquine and risperidone [75] Mefloquine, risperidone and" exact="cytarabine" post="[120] Mefloquine and cidofovir [121] Mefloquine and PML standard"/>
  <result pre="and risperidone [75] Mefloquine, risperidone and cytarabine [120] Mefloquine and" exact="cidofovir" post="[121] Mefloquine and PML standard of care [129] Filoviridae"/>
 </snippets>
</snippetsTree>
